Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Feb;14(2):69-70.
doi: 10.1111/j.1751-7176.2011.00562.x. Epub 2011 Nov 15.

β-blockade: benefits beyond blood pressure reduction?

Affiliations
Comment

β-blockade: benefits beyond blood pressure reduction?

Clive Rosendorff. J Clin Hypertens (Greenwich). 2012 Feb.
No abstract available

PubMed Disclaimer

Comment on

  • β-blockade: benefits beyond blood pressure reduction?
    Cockcroft JR, Pedersen ME. Cockcroft JR, et al. J Clin Hypertens (Greenwich). 2012 Feb;14(2):112-120. doi: 10.1111/j.1751-7176.2011.00553.x. Epub 2011 Nov 11. J Clin Hypertens (Greenwich). 2012. PMID: 22277144 Free PMC article. Review.

References

    1. Cockroft JR, Pedersen ME. Beta‐blockade: benefits beyond blood pressure reduction? J Clin Hypertens (Greenwich). DOI: 10.1111/j.1751‐7176.2011.00552.x. - PMC - PubMed
    1. Salpeter S, Ormiston T, Salpeter E. Cardioselective beta‐blockers for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2005;4:CD003566. - PMC - PubMed
    1. Brixius K, Bundkirchen A, Bölck B, et al. Nebivolol, bucindolol, metoprolol and carvedilol are devoid of intrinsic sympathomimetic activity in the human myocardium. Br J Pharmacol. 2001;133:1330–1338. - PMC - PubMed
    1. Dal Negro R. Pulmonary effects of nebivolol. Ther Adv Cardiovasc Dis. 2009;3:329–334. - PubMed
    1. Rejnmark L, Vestergaard P, Mosekilde L. Treatment with beta‐blockers, ACE inhibitors, and calcium‐channel blockers is associated with a reduced fracture risk: a nationwide case‐control study. J Hypertens. 2006;24:581–589. - PubMed

Substances